A New Weight Loss Drug
An FDA panel consisting of 20 experts voted 13 to 7 in favor of approving the weight loss drug Contrave, with an abstention that additional studies be conducted related to heart risks. Safety concerns were considered, but it was determined that the pros of the medication outweighed the cons. Two weight loss drugs were rejected by the FDA panel just this past October due to safety concerns.
What is Contrave?
The weight loss drug Contrave is a combination of the antidepressant buproprion and the anti-addiction drug naltrexone. Some of the side effects reported by the FDA include high blood pressure, dizziness, and insomnia.
